The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

Inherited resistance to activated protein C is a thrombophilic condition resulting from a mutant factor V (factor V Leiden). 1 The mutation is relatively common among whites, with a frequency of 5 percent in the general population of European ancestry and 11 to 21 percent among patients with venous...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1999-09, Vol.341 (11), p.801-806
Hauptverfasser: De Stefano, Valerio, Martinelli, Ida, Mannucci, Pier Mannuccio, Paciaroni, Katia, Chiusolo, Patrizia, Casorelli, Ida, Rossi, Elena, Leone, Giuseppe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 806
container_issue 11
container_start_page 801
container_title The New England journal of medicine
container_volume 341
creator De Stefano, Valerio
Martinelli, Ida
Mannucci, Pier Mannuccio
Paciaroni, Katia
Chiusolo, Patrizia
Casorelli, Ida
Rossi, Elena
Leone, Giuseppe
description Inherited resistance to activated protein C is a thrombophilic condition resulting from a mutant factor V (factor V Leiden). 1 The mutation is relatively common among whites, with a frequency of 5 percent in the general population of European ancestry and 11 to 21 percent among patients with venous thromboembolism. 2 The estimated risk of deep venous thrombosis is 7 times as high among heterozygous carriers of the mutation as among persons without the mutation, and 80 times as high among homozygotes. 3 There is disagreement whether factor V Leiden is associated with an increased risk of recurrent deep venous thrombosis. Several studies . . .
doi_str_mv 10.1056/NEJM199909093411104
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69996902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69996902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c593t-d617f04e8976edb3a58087bade2ffb56c071ad4cae129b234f01cd26121562523</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EotOWX4CELITYoFC_4sTLdugDNG1RNXQbOc5Nx8PEHmxn0e753ziakUAIcb3wwt85x_ZB6DUlHykp5cnN-ZdrqpQieXFBKSXiGZrRkvNCCCKfoxkhrC5EpfgBOoxxTfJQoV6ig4xWeeoZ-rlcAb6z8Tv2Pb4DM4YALuFPAFt8D86PES9XwQ-tjzZiPXj3gK8gQfBPjw_T6VyHYCHESX_m0wpfaJN8wPd4AbYDh7XrcMohl4wwSk7x15CpydE6fD0mnax3x-hFrzcRXu33I_Tt4nw5vyoWt5ef56eLwpSKp6KTtOqJgFpVErqW67ImddXqDljft6U0pKK6E0YDZaplXPSEmo5JymgpWcn4EXq_890G_2OEmJrBRgObjXaQH9PI_J1SkQl8-xe49mNw-W4NY1zxSgqaIb6DTPAxBuibbbCDDo8NJc1UUfOPirLqzd56bAfo_tDsOsnAuz2go9GbPmhnbPzN5XRCZMY-7LBhiI2D9fDf1F-ECaQF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223937641</pqid></control><display><type>article</type><title>The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>De Stefano, Valerio ; Martinelli, Ida ; Mannucci, Pier Mannuccio ; Paciaroni, Katia ; Chiusolo, Patrizia ; Casorelli, Ida ; Rossi, Elena ; Leone, Giuseppe</creator><creatorcontrib>De Stefano, Valerio ; Martinelli, Ida ; Mannucci, Pier Mannuccio ; Paciaroni, Katia ; Chiusolo, Patrizia ; Casorelli, Ida ; Rossi, Elena ; Leone, Giuseppe</creatorcontrib><description>Inherited resistance to activated protein C is a thrombophilic condition resulting from a mutant factor V (factor V Leiden). 1 The mutation is relatively common among whites, with a frequency of 5 percent in the general population of European ancestry and 11 to 21 percent among patients with venous thromboembolism. 2 The estimated risk of deep venous thrombosis is 7 times as high among heterozygous carriers of the mutation as among persons without the mutation, and 80 times as high among homozygotes. 3 There is disagreement whether factor V Leiden is associated with an increased risk of recurrent deep venous thrombosis. Several studies . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199909093411104</identifier><identifier>PMID: 10477778</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Blood vessels ; Child ; Cohort Studies ; Disease-Free Survival ; Factor V - genetics ; Female ; Genetics ; Health risk assessment ; Hematologic and hematopoietic diseases ; Heterozygote ; Humans ; Incidence ; Male ; Medical disorders ; Medical sciences ; Middle Aged ; Mutation ; Platelet diseases and coagulopathies ; Point Mutation ; Prothrombin - genetics ; Recurrence ; Retrospective Studies ; Risk ; Risk Factors ; Venous Thrombosis - epidemiology ; Venous Thrombosis - genetics</subject><ispartof>The New England journal of medicine, 1999-09, Vol.341 (11), p.801-806</ispartof><rights>Copyright © 1999 Massachusetts Medical Society. All rights reserved.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c593t-d617f04e8976edb3a58087bade2ffb56c071ad4cae129b234f01cd26121562523</citedby><cites>FETCH-LOGICAL-c593t-d617f04e8976edb3a58087bade2ffb56c071ad4cae129b234f01cd26121562523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199909093411104$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/223937641?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,2746,2747,26084,27905,27906,52363,54045,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1937006$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10477778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Stefano, Valerio</creatorcontrib><creatorcontrib>Martinelli, Ida</creatorcontrib><creatorcontrib>Mannucci, Pier Mannuccio</creatorcontrib><creatorcontrib>Paciaroni, Katia</creatorcontrib><creatorcontrib>Chiusolo, Patrizia</creatorcontrib><creatorcontrib>Casorelli, Ida</creatorcontrib><creatorcontrib>Rossi, Elena</creatorcontrib><creatorcontrib>Leone, Giuseppe</creatorcontrib><title>The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Inherited resistance to activated protein C is a thrombophilic condition resulting from a mutant factor V (factor V Leiden). 1 The mutation is relatively common among whites, with a frequency of 5 percent in the general population of European ancestry and 11 to 21 percent among patients with venous thromboembolism. 2 The estimated risk of deep venous thrombosis is 7 times as high among heterozygous carriers of the mutation as among persons without the mutation, and 80 times as high among homozygotes. 3 There is disagreement whether factor V Leiden is associated with an increased risk of recurrent deep venous thrombosis. Several studies . . .</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood vessels</subject><subject>Child</subject><subject>Cohort Studies</subject><subject>Disease-Free Survival</subject><subject>Factor V - genetics</subject><subject>Female</subject><subject>Genetics</subject><subject>Health risk assessment</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical disorders</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Platelet diseases and coagulopathies</subject><subject>Point Mutation</subject><subject>Prothrombin - genetics</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Venous Thrombosis - epidemiology</subject><subject>Venous Thrombosis - genetics</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kUtv1DAUhS0EotOWX4CELITYoFC_4sTLdugDNG1RNXQbOc5Nx8PEHmxn0e753ziakUAIcb3wwt85x_ZB6DUlHykp5cnN-ZdrqpQieXFBKSXiGZrRkvNCCCKfoxkhrC5EpfgBOoxxTfJQoV6ig4xWeeoZ-rlcAb6z8Tv2Pb4DM4YALuFPAFt8D86PES9XwQ-tjzZiPXj3gK8gQfBPjw_T6VyHYCHESX_m0wpfaJN8wPd4AbYDh7XrcMohl4wwSk7x15CpydE6fD0mnax3x-hFrzcRXu33I_Tt4nw5vyoWt5ef56eLwpSKp6KTtOqJgFpVErqW67ImddXqDljft6U0pKK6E0YDZaplXPSEmo5JymgpWcn4EXq_890G_2OEmJrBRgObjXaQH9PI_J1SkQl8-xe49mNw-W4NY1zxSgqaIb6DTPAxBuibbbCDDo8NJc1UUfOPirLqzd56bAfo_tDsOsnAuz2go9GbPmhnbPzN5XRCZMY-7LBhiI2D9fDf1F-ECaQF</recordid><startdate>19990909</startdate><enddate>19990909</enddate><creator>De Stefano, Valerio</creator><creator>Martinelli, Ida</creator><creator>Mannucci, Pier Mannuccio</creator><creator>Paciaroni, Katia</creator><creator>Chiusolo, Patrizia</creator><creator>Casorelli, Ida</creator><creator>Rossi, Elena</creator><creator>Leone, Giuseppe</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19990909</creationdate><title>The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation</title><author>De Stefano, Valerio ; Martinelli, Ida ; Mannucci, Pier Mannuccio ; Paciaroni, Katia ; Chiusolo, Patrizia ; Casorelli, Ida ; Rossi, Elena ; Leone, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c593t-d617f04e8976edb3a58087bade2ffb56c071ad4cae129b234f01cd26121562523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood vessels</topic><topic>Child</topic><topic>Cohort Studies</topic><topic>Disease-Free Survival</topic><topic>Factor V - genetics</topic><topic>Female</topic><topic>Genetics</topic><topic>Health risk assessment</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical disorders</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Platelet diseases and coagulopathies</topic><topic>Point Mutation</topic><topic>Prothrombin - genetics</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Venous Thrombosis - epidemiology</topic><topic>Venous Thrombosis - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Stefano, Valerio</creatorcontrib><creatorcontrib>Martinelli, Ida</creatorcontrib><creatorcontrib>Mannucci, Pier Mannuccio</creatorcontrib><creatorcontrib>Paciaroni, Katia</creatorcontrib><creatorcontrib>Chiusolo, Patrizia</creatorcontrib><creatorcontrib>Casorelli, Ida</creatorcontrib><creatorcontrib>Rossi, Elena</creatorcontrib><creatorcontrib>Leone, Giuseppe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Stefano, Valerio</au><au>Martinelli, Ida</au><au>Mannucci, Pier Mannuccio</au><au>Paciaroni, Katia</au><au>Chiusolo, Patrizia</au><au>Casorelli, Ida</au><au>Rossi, Elena</au><au>Leone, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1999-09-09</date><risdate>1999</risdate><volume>341</volume><issue>11</issue><spage>801</spage><epage>806</epage><pages>801-806</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Inherited resistance to activated protein C is a thrombophilic condition resulting from a mutant factor V (factor V Leiden). 1 The mutation is relatively common among whites, with a frequency of 5 percent in the general population of European ancestry and 11 to 21 percent among patients with venous thromboembolism. 2 The estimated risk of deep venous thrombosis is 7 times as high among heterozygous carriers of the mutation as among persons without the mutation, and 80 times as high among homozygotes. 3 There is disagreement whether factor V Leiden is associated with an increased risk of recurrent deep venous thrombosis. Several studies . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>10477778</pmid><doi>10.1056/NEJM199909093411104</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1999-09, Vol.341 (11), p.801-806
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_69996902
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Adolescent
Adult
Aged
Biological and medical sciences
Blood vessels
Child
Cohort Studies
Disease-Free Survival
Factor V - genetics
Female
Genetics
Health risk assessment
Hematologic and hematopoietic diseases
Heterozygote
Humans
Incidence
Male
Medical disorders
Medical sciences
Middle Aged
Mutation
Platelet diseases and coagulopathies
Point Mutation
Prothrombin - genetics
Recurrence
Retrospective Studies
Risk
Risk Factors
Venous Thrombosis - epidemiology
Venous Thrombosis - genetics
title The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A03%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Recurrent%20Deep%20Venous%20Thrombosis%20among%20Heterozygous%20Carriers%20of%20Both%20Factor%20V%20Leiden%20and%20the%20G20210A%20Prothrombin%20Mutation&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=De%20Stefano,%20Valerio&rft.date=1999-09-09&rft.volume=341&rft.issue=11&rft.spage=801&rft.epage=806&rft.pages=801-806&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM199909093411104&rft_dat=%3Cproquest_cross%3E69996902%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223937641&rft_id=info:pmid/10477778&rfr_iscdi=true